Abstract
C3H/He mice bearing SCC VII tumours received 5-bromo-2'-deoxyuridine (BrdU) continuously for 5 days via implanted mini-osmotic pumps in order to label all proliferating (P) cells. The tumours were then heated at 40 degrees C for 60 min. At various time points after heating, tumour-bearing mice were irradiated while alive or after being killed. Immediately after irradiation, the tumours were excised, minced and trypsinized. The tumour cell suspensions obtained were incubated with cytochalasin-B (a cytokinesis blocker), and the micronucleus (MN) frequency in cells without BrdU labelling, which could be regarded as quiescent (Q) cells, was determined using immunofluorescence staining for BrdU. The MN frequency in the total (P+Q) tumour cell population was determined from the irradiated tumours that were not pretreated with BrdU. The MN frequency of BrdU unlabelled cells was then used to calculate the surviving fraction of the unlabelled cells from the regression line for the relationship between the MN frequency and the surviving fraction of total (P+Q) tumour cells. In general, Q cells contained a greater hypoxic fraction (HF) than the total tumour cell population. Mild heating decreased the HF of Q cells more markedly than in the total cell population, and the minimum values of HFs of both total and Q cell populations were obtained 6 h after heating. Two days after heating, the HF of total tumour cells returned to almost that of unheated tumours. In contrast, the HF of Q cells did not return to the HF level of unheated tumours until 1 week after heating. It was thought that irradiation within 12 h after mild heating might be a potentially promising therapeutic modality for controlling radioresistant Q tumour cells.
Full text
PDF





Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Brown J. M. Evidence for acutely hypoxic cells in mouse tumours, and a possible mechanism of reoxygenation. Br J Radiol. 1979 Aug;52(620):650–656. doi: 10.1259/0007-1285-52-620-650. [DOI] [PubMed] [Google Scholar]
- Coleman C. N. Hypoxia in tumors: a paradigm for the approach to biochemical and physiologic heterogeneity. J Natl Cancer Inst. 1988 May 4;80(5):310–317. doi: 10.1093/jnci/80.5.310. [DOI] [PubMed] [Google Scholar]
- Dewey W. C. Arrhenius relationships from the molecule and cell to the clinic. Int J Hyperthermia. 1994 Jul-Aug;10(4):457–483. doi: 10.3109/02656739409009351. [DOI] [PubMed] [Google Scholar]
- Iwata K., Shakil A., Hur W. J., Makepeace C. M., Griffin R. J., Song C. W. Tumour pO2 can be increased markedly by mild hyperthermia. Br J Cancer Suppl. 1996 Jul;27:S217–S221. [PMC free article] [PubMed] [Google Scholar]
- Jackson R. C. The problem of the quiescent cancer cell. Adv Enzyme Regul. 1989;29:27–46. doi: 10.1016/0065-2571(89)90092-7. [DOI] [PubMed] [Google Scholar]
- Luk C. K., Keng P. C., Sutherland R. M. Regrowth and radiation sensitivity of quiescent cells isolated from EMT6/Ro-fed plateau monolayers. Cancer Res. 1985 Mar;45(3):1020–1025. [PubMed] [Google Scholar]
- Masunaga S., Ono K., Abe M. A method for the selective measurement of the radiosensitivity of quiescent cells in solid tumors--combination of immunofluorescence staining to BrdU and micronucleus assay. Radiat Res. 1991 Mar;125(3):243–247. [PubMed] [Google Scholar]
- Masunaga S., Ono K., Abe M. The detection and modification of the hypoxic fraction in quiescent cell populations in murine solid tumours. Br J Radiol. 1993 Oct;66(790):918–926. doi: 10.1259/0007-1285-66-790-918. [DOI] [PubMed] [Google Scholar]
- Masunaga S., Ono K., Wandl E. O., Fushiki M., Abe M. Use of the micronucleus assay for the selective detection of radiosensitivity in BUdR-unincorporated cells after pulse-labelling of exponentially growing tumour cells. Int J Radiat Biol. 1990 Aug;58(2):303–311. doi: 10.1080/09553009014551641. [DOI] [PubMed] [Google Scholar]
- Mitchell J. B., Morstyn G., Russo A., Kinsella T. J., Fornace A., Jr, McPherson S., Glatstein E. Differing sensitivity to fluorescent light in Chinese hamster cells containing equally incorporated quantities of BUdR versus IUdR. Int J Radiat Oncol Biol Phys. 1984 Aug;10(8):1447–1451. doi: 10.1016/0360-3016(84)90366-3. [DOI] [PubMed] [Google Scholar]
- Moulder J. E., Rockwell S. Hypoxic fractions of solid tumors: experimental techniques, methods of analysis, and a survey of existing data. Int J Radiat Oncol Biol Phys. 1984 May;10(5):695–712. doi: 10.1016/0360-3016(84)90301-8. [DOI] [PubMed] [Google Scholar]
- Nishimura Y., Hiraoka M., Jo S., Akuta K., Yukawa Y., Shibamoto Y., Takahashi M., Abe M. Microangiographic and histologic analysis of the effects of hyperthermia on murine tumor vasculature. Int J Radiat Oncol Biol Phys. 1988 Aug;15(2):411–420. doi: 10.1016/s0360-3016(98)90023-2. [DOI] [PubMed] [Google Scholar]
- Nishimura Y., Ono K., Hiraoka M., Masunaga S., Jo S., Shibamoto Y., Sasai K., Abe M., Iga K., Ogawa Y. Treatment of murine SCC VII tumors with localized hyperthermia and temperature-sensitive liposomes containing cisplatin. Radiat Res. 1990 May;122(2):161–167. [PubMed] [Google Scholar]
- Oleson J. R. Eugene Robertson Special Lecture. Hyperthermia from the clinic to the laboratory: a hypothesis. Int J Hyperthermia. 1995 May-Jun;11(3):315–322. doi: 10.3109/02656739509022467. [DOI] [PubMed] [Google Scholar]
- Oleson J. R., Samulski T. V., Leopold K. A., Clegg S. T., Dewhirst M. W., Dodge R. K., George S. L. Sensitivity of hyperthermia trial outcomes to temperature and time: implications for thermal goals of treatment. Int J Radiat Oncol Biol Phys. 1993 Jan 15;25(2):289–297. doi: 10.1016/0360-3016(93)90351-u. [DOI] [PubMed] [Google Scholar]
- Ono K., Wandl E., Tsutsui K., Sasai K., Abe M. The correlation between cell survival curve and dose response curve of micronucleus (MN) frequency. Strahlenther Onkol. 1989 Nov;165(11):824–827. [PubMed] [Google Scholar]
- Overgaard J., Gonzalez Gonzalez D., Hulshof M. C., Arcangeli G., Dahl O., Mella O., Bentzen S. M. Randomised trial of hyperthermia as adjuvant to radiotherapy for recurrent or metastatic malignant melanoma. European Society for Hyperthermic Oncology. Lancet. 1995 Mar 4;345(8949):540–543. doi: 10.1016/s0140-6736(95)90463-8. [DOI] [PubMed] [Google Scholar]
- Overgaard J. Sensitization of hypoxic tumour cells--clinical experience. Int J Radiat Biol. 1989 Nov;56(5):801–811. doi: 10.1080/09553008914552081. [DOI] [PubMed] [Google Scholar]
- Song C. W., Shakil A., Osborn J. L., Iwata K. Tumour oxygenation is increased by hyperthermia at mild temperatures. Int J Hyperthermia. 1996 May-Jun;12(3):367–373. doi: 10.3109/02656739609022525. [DOI] [PubMed] [Google Scholar]
- Valdagni R., Liu F. F., Kapp D. S. Important prognostic factors influencing outcome of combined radiation and hyperthermia. Int J Radiat Oncol Biol Phys. 1988 Oct;15(4):959–972. doi: 10.1016/0360-3016(88)90133-2. [DOI] [PubMed] [Google Scholar]
